It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Synthesis and antiinflammatory activity of n-aryl anthranilic acid and its derivatives Joshi J K, Patel V R, Patel K, Rana D, Shah K, Patel R, Patel R - Indian J Pharm Sci
Indian Journal of Pharmaceutical Sciences
Users online: 81
Scientific Publication of the Indian Pharmaceutical Association
Home Email this page Print this page Bookmark this page Decrease font size Default font size Increase font size
The Journal Search Current Issue Archives Instructions Online submission Login  


 
SHORT COMMUNICATION
Year : 2007  |  Volume : 69  |  Issue : 5  |  Page : 697-699
Synthesis and antiinflammatory activity of n-aryl anthranilic acid and its derivatives


Department of Pharmaceutical Chemistry, Maliba Pharmacy College, Tarsadi, Surat - 394 350, India

Date of Submission 07-Apr-2006
Date of Decision 25-Apr-2007
Date of Acceptance 17-Oct-2007

Correspondence Address:
J K Joshi
Department of Pharmaceutical Chemistry, Maliba Pharmacy College, Tarsadi, Surat - 394 350
India
Login to access the Email id


DOI: 10.4103/0250-474X.38483

Get Permissions

   Abstract  

N-aryl anthranilic acid and its derivatives (3a-f) have been synthesized via Ullmann condensation of o-chloro benzoic acid with various substituted anilines (2a-f) in the presence of cupric oxide and anhydrous potassium carbonate. All the synthesized compounds (3a-f) were characterized by mp, TLC, UV, IR, 1 H NMR and mass spectral analysis. All the synthesized compounds (3a-f) were screened for their antiinflammatory activity by carrageenan induced rat paw edema method. All the synthesized compounds (3a-f) showed significant antiinflammatory activity. Compounds 3a and 3c were found to be the most potent compounds.



How to cite this article:
Joshi J K, Patel V R, Patel K, Rana D, Shah K, Patel R, Patel R. Synthesis and antiinflammatory activity of n-aryl anthranilic acid and its derivatives. Indian J Pharm Sci 2007;69:697-9

How to cite this URL:
Joshi J K, Patel V R, Patel K, Rana D, Shah K, Patel R, Patel R. Synthesis and antiinflammatory activity of n-aryl anthranilic acid and its derivatives. Indian J Pharm Sci [serial online] 2007 [cited 2014 Mar 5];69:697-9. Available from: http://www.ijpsonline.com/text.asp?2007/69/5/697/38483


In the present investigation an attempt has been made to synthesize N-aryl anthranilic acid and its derivatives (3a-f) and to evaluate their antiinflammatory activity. All the compounds (3a-f) were synthesized by Ullmann condensation of o-chlorobenzoic acid with various substituted anilines (2a-f) in the presence of cupric oxide (catalyst) and anhydrous potassium carbonate (for removal of hydrogen halide formed during reaction). Chlorobenzene itself is mostly unreactive, but it is activated by introduction of certain functional groups like carboxylic acid. Several compounds such as mefenamic acid, flufenamic acid, clofenamic acid, medofenamic acid and tolfenamate [1],[2],[3],[4] have been demonstrated to possess antiinflammatory [5] , analgesic [6] , antipyretic [7] activity. Therefore, it was a thought of interest to synthesize and study biological effects of various N-aryl anthranilic acid derivatives.

Melting points of synthesized compounds were determined in open capillary tubes and are uncorrected. Thin layer chromatography was performed on microscopic slides coated with silica gel G, benzene:methanol (4.9:0.1) was used as mobile phase and spots were visualized by overnight exposure to iodine vapour. The structure of compounds was established on the basis of complete spectral analysis. The UV spectra were recorded on Shimadzu UV/Vis spectrophotometer. The IR spectra were recorded in the range of 4000-400 cm -1 using KBr disc on a FTIR RXI Perkin Elmer spectrophotometer. 1 H NMR were recorded on a Broker dry 300 KHz spectrophotometer using CDCl 3 /DMSO-d 6 as a solvent with TMS as an internal standard. The FAB mass spectra were recorded on a Joel Sx-102/Da-6000 spectrophotometer data system using xenon as FAB gas.

N-aryl anthranilic acid and its derivatives (3a-f) [8] were synthesized by refluxing a mixture of o-chloro benzoic acid (1 mol) (1), various substituted anilines (1.2 mol) (2a-f), upric oxide (1 g) and anhydrous potassium carbonate (8 g) was heated under reflux for 7 h [Figure - 1] The solid thus obtained was suspended in water. Finally title compounds (3a-f) were precipitated with the help of dilute hydrochloric acid, dried and recrystallised from ethanol (95%).

The study was carried out according to the rules and regulation laid down by the Institutional Animal Ethics Committee. Animals (rats) were weighed, numbered and marked on one of the hind paw just beyond tibio-tarsal junction to ensure accurate paw volume. The paw volume of each rat was determined by mercury displacement method [9],[10],[11],[12] . The animals were divided into two groups, one as control and other as test, each comprising of two rats. To one group (test) was injected N,N-dimethylformamide solution of synthesized compounds intraperitonialy and to the second group (control) was injected N,N-dimethylformamide solution. 0.1 ml of 1% w/v carrageenan was injected in the plantar region of the paw of control as well as synthesized compound- treated group after 30 min. The rat paw volume of legs of control and synthesized compound treated rats were noted at 15, 30, 45, 60, 75, 90, 105 and 120 min interval after carrageenan challenge. The % inhibition [13],[14],[15],[16] of paw volume in drug-treated animals taking control as reference was calculated at 60 min interval.

O-chlorobenzoic acid on reaction with various substituted aniline derivatives (2a-f) produced N-aryl anthranilic acid derivatives (3a-f) in good yield. The structure of compound 3a has been proved by UV, IR, 1H NMR and mass spectral data. The UV spectra showed two absorption maxima at 298 nm and 388 nm, respectively. The IR absorption due to (C=O), (-OH) and (-NH-) appeared at 1710-1678 cm -1 , 3300-2600 cm -1 and 3280-3110 cm -1 , respectively. The 1 H NMR spectra of this compound in DMSO-d 6 exhibited following signals: (δ in ppm) 6.692-7.353 ( m, 9H, Ar-H), 7.961 (s, 1H, N-H), 9.639 (s, 1H, -COOH). The mass spectrum showed a fairly intense molecular ion peak at m/z 213 (M + ), conforming the molecular formula C 13 H 11 O 2 N of this compound. The structure of other compounds (3b-f) was also proved by the same manner.

The reaction conditions however were depended upon aromatic substituents (3a-f). Reflux time for completion of reaction varied between 6-8 h. A dilute solution of hydrochloric acid in water was best suitable for reprecipitation of synthesized compounds. The complete structure was elucidated on the basis of physical, chemical and spectral studies. The physical and spectral data are presented in [Table - 1],[Table - 2].

Using 100 mg/kg body weight concentration in N,N-dimethylformamide, the synthesized compounds (3a-f) were tested in vivo for antiinflammatory activity taking N,N-dimethylformamide as a control [Table - 3]. The result showed that the activity depends upon type and position of the substituents. For example compound 3c is more active among others. It can be concluded from antiinflammatory activity that the N-aryl anthranilic acid derivatives showed good activity and may be explored for inflammatory disease.


   Acknowledgements   Top


We thank Mr. D. R. Shah (Director, Maliba Pharmacy College, Surat) for providing laboratory facility and chemical reagents. We also thank Dr. M. T. Chhabria (Assistant Professor, L. M. College of Pharmacy, Ahmedabad) for providing FTIR spectra of the synthesized compounds. We are grateful to Central Drug Research Institute, Lucknow for providing facility of 1 H NMR and mass spectra.

 
   References   Top

1. Cioli, V., Putzolu, S., Rossi, V. and Carrondine, C., Toxicol. Appl. Pharmacol., 1979, 50, 283.  Back to cited text no. 1    
2. Robert, T.S. and Ronald, J.V., Amer. J. Med., 1989, 86, 449.  Back to cited text no. 2    
3. Allan, H.P. and Fletcher, M., Drugs, 1990, 50, 1.  Back to cited text no. 3    
4. Tammata, V.K., Narutkar, M.M., Crinder, A.M. and Khan, M.A., Pharma. Res., 1993, 10, 1191.  Back to cited text no. 4    
5. Furukawa, S. and Oshitak, M., Jpn. Kokai Tokyo Koyo, Jp., 1987, 62, 71, through Chem. Abstr., 1987, 107, 77826j.  Back to cited text no. 5    
6. Takehiko, N., Yoshiyasu, F. and Akinobu, N., Eur. Pat. Appli. Ep., 1987, 237, 289, through Chem. Abstr., 1988, 108, 37857j.  Back to cited text no. 6    
7. Machon, Z. and Krystyna, W., Acta. Pol. Pharma., 1985, 42, 516.  Back to cited text no. 7    
8. Mann, F.G. and Saunders, B.C., Practical Organic Chemistry, 4th edition, new impression, 303.  Back to cited text no. 8    
9. Collier, H.O.J., Dinnen, L.C. and Johnsan, C.A., Brit. J. Pharmacol. Chemother., 1968, 32, 295.  Back to cited text no. 9    
10. Ghosh, M.N., Editors, In; Toxicology study in fundamental Pharmacology , Scientific Book Agency, Calcutta, 1984, 320.  Back to cited text no. 10    
11. Penn, G.B. and Ashford, A. J. Pharm. Pharmacol., 1963, 15, 798.  Back to cited text no. 11    
12. Kulkarni, S.K., In; Handbook of Experimental Pharmacology, Vallabh Prakashan, Delhi, 1987, 65.  Back to cited text no. 12    
13. Rathod, I.S. and Baheti, K.G., Indian J. Pharm. Sci., 2005, 67, 593.  Back to cited text no. 13    
14. Winter, C.A., Risley, E.A. and Nuss, G.W., Proc. Soc. Exp. Biol. Med., 1962, 111, 544.  Back to cited text no. 14    
15. Singh, H. and Gosh, M., J. Pharm. Pharmacol., 1968, 20, 316.  Back to cited text no. 15    
16. Vogel, G., In; Drug Discovery and Evaluation, Springer-Verlag, New York, 2002, 725.  Back to cited text no. 16    


    Figures

  [Figure - 1]
 
 
    Tables

  [Table - 1], [Table - 2], [Table - 3]

This article has been cited by
1 Synthesis and investigation of anti-inflammatory activity of novel nitric oxide donating hybrid drugs
Shailesh L. Chandak,Amol S. Bansode,Prashant R. Murumkar,Monika G. Shinde,Kailash G. Bothara
Medicinal Chemistry Research. 2013; 22(7): 3510
[Pubmed]
2 Catalysis and mechanistic studies of ruthenium and osmium on synthesis of anthranilic acids
P. Karthikeyan, Rajenahally V. Jagadeesh, Y. Sree Sandhya, Puttaswamy, P. Nithya, S. Senthil Kumar, P.R. Bhagat
Applied Organometallic Chemistry. 2011; 25(1): 34
[VIEW]
3 Design, Synthesis and Evaluation of Substituted N-(3-Arylpropyl)-9,10-dihydro-9-oxoacridine-4-carboxamides as Potent MDR Reversal Agents in Cancer
V. S. Velingkar, V. D. Dandekar
Chinese Journal of Chemistry. 2011; 29(3): 504
[VIEW]
4 Bromamine-B/PdCl2 is an efficient system for the synthesis of anthranilic acids from indoles and indigos
Kumar, C.V., Shivananda, K.N., Raju, C.N., Jagadeesh, R.V.
Synthetic Communications. 2010; 40(23): 3480-3487
[Pubmed]
5 Synthesis of some novel schiffæs bases of N-aryl anthranilic acid derivatives
Muthumani, P., Meera, R., Venkatraman, S., Murugan, Devi, P., Kameswari, B., Eswarapriya, B.
International Journal of Applied Chemistry. 2010; 6(2): 185-191
[Pubmed]
6 Bromamine-B/PdCl<sub>2</sub> is an Efficient System for the Synthesis of Anthranilic Acids from Indoles and Indigos
C. H. Vinod Kumar, K. N. Shivananda, C. Nagu Raju, R. V. Jagadeesh
Synthetic Communications. 2010; 40(23): 3480
[VIEW]



 

Top
Print this article  Email this article
 
  Search
   
   Next article
   Previous article 
   Table of Contents
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (232 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
    Acknowledgements
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed 4599    
    Printed 110    
    Emailed 2    
    PDF Downloaded 378    
    Comments  [Add]    
    Cited by others  6    

Recommend this journal